Anonymous Medical Device Manufacturer

A medical device manufacturer operating at enterprise scale faced a hard ceiling on production capacity within its existing facility footprint. Medical device assembly demands precise, repeatable handling across multiple process steps — often with strict traceability and contamination control requirements. Conventional fixed conveyor systems lack the flexibility to accommodate product mix changes or parallel processing paths, forcing the manufacturer to choose between costly facility expansion or accepting throughput limits that constrained its ability to meet market demand. The inability to scale production without adding floor space represented a significant competitive and operational constraint.

The manufacturer deployed Rockwell Automation's MagneMotion Independent Cart Technology (ICT), an intelligent transport system that uses magnetically driven, independently controlled carts on a shared track. Unlike fixed-speed conveyors, each cart moves autonomously, enabling parallel processing, variable station dwell times, and dynamic routing — all within the same physical footprint. This flexibility is critical in medical device assembly, where different product configurations may require different process sequences. The MagneMotion system integrates with Rockwell's broader Allen-Bradley control architecture, allowing the transport layer to communicate directly with assembly stations and process controllers. This tight integration enabled precise coordination between cart positioning and workstation operations without requiring a full line redesign.

The implementation delivered a 2x increase in production capacity — doubling output within the existing facility without floor space expansion. Key outcomes include:

• Production capacity doubled in the same manufacturing footprint
• Flexible routing enabled the line to handle multiple product configurations simultaneously
• Independent cart control eliminated the pacing constraints of fixed-speed conveyors, reducing idle time at individual stations
• The intelligent transport system improved traceability by enabling per-cart tracking through each assembly stage

The capacity gain was achieved through throughput optimization rather than capital-intensive facility expansion, improving the return on existing infrastructure investment.

• Footprint constraints don't have to limit capacity — independent cart technology can unlock significant throughput gains within an existing facility by eliminating fixed-conveyor bottlenecks.
• Flexible routing is a force multiplier in mixed-product environments — the ability to route different SKUs through different station sequences on the same line reduces changeover overhead.
• Integration with existing control infrastructure is critical; systems that communicate natively with PLCs and process controllers reduce implementation risk and commissioning time.
• Medical device applications benefit particularly from per-cart traceability, which supports regulatory documentation requirements without separate tracking systems.
• Evaluate intelligent transport as a capacity investment, not just a material handling upgrade — the operational leverage often justifies the cost over facility expansion.